If the advisory panel recommends, and the FDA agrees, that compounding eligibility should be determined primarily by market demand and political pressure rather than clinical evidence, the integrity of the drug approval system faces a meaningful structural challenge
In published rodent studies, BPC-157 has been more extensively investigated for gastrointestinal mucosal protection, tendon-to-bone healing, and organ damage models, whereas TB-500 research has concentrated on dermal wound closure rates, cardiac tissue repair after ischemia, and corneal epithelial recovery
Past efforts often lacked credible user behavior, protocol fidelity, or exhibited static responsesmaking them too easy to spot
Testing is essential before starting therapy, and treatment is typically tailored to individual needs and exposure levels
World Health Organization: WHO laboratory manual for the examination of human semen and semen-cervical mucus interaction
Bryan is giving us something worth more than what we would charge him. But why would Johnson forgo FDA approvals to become a human guinea pig for the startup
.jpg)
